Neonatal thrombocytopenia and platelet transfusion - A UK perspective

Neonatology

Volumn 107, Issue 1, 2015, Pages 1-7

  Carr, Robert ^a   Kelly, Anne M ^b   Williamson, Lorna M ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Infant; Newborn; Platelet transfusion; Thrombocytopenia

Indexed keywords

RECOMBINANT THROMBOPOIETIN; THROMBOPOIETIN;

ALTERNATIVE MEDICINE; AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING DISORDER; BLOOD; BLOOD CELL COUNT; HEALTH CARE POLICY; HUMAN; INTENSIVE CARE UNIT; INTRAUTERINE INFECTION; LABORATORY; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEONATAL THROMBOCYTOPENIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPTICEMIA; SMALL FOR DATE INFANT; STEM CELL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS; TREATMENT INDICATION; UNITED KINGDOM; HEMORRHAGE; NEEDS ASSESSMENT; NEWBORN; PRACTICE GUIDELINE; PROCEDURES; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

GREAT BRITAIN; HEMORRHAGE; HUMANS; INFANT, NEWBORN; NEEDS ASSESSMENT; PLATELET COUNT; PLATELET TRANSFUSION; PRACTICE GUIDELINES AS TOPIC; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84918784186     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000365163     Document Type: Review

References (39)

1. Christensen RD, Henry E, Weidmeier SE, Stoddard RA, Sola-Visner MC, Lambert DK, Kiehn TI, Ainsworth S: Thrombocytopenia among extremely low birth weight neonates: Data from a multihospital healthcare system. J Perinatol 2006; 26: 348-353.
2. Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD: Platelet reference ranges for neonates, defined using data from over 47, 000 patients in a multihospital healthcare system. J Perinatol 2009; 29: 130-136.
3. Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C: Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986; 108: 749-755.
4. Murray NA, Roberts IAG: Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res 1996; 40: 112-119.
5. Watts TL, Murray NA, Roberts IAG: Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. Pediatr Res 1999; 28: 28-32.
6. Carr R, Brocklehurst P, Dore CD, Modi N: Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): A single-blind, multicentre, randomised controlled trial. Lancet 2009; 373: 226-233.
7. Roberts IAG, Murray NA: Neonatal thrombocytopenia: Causes and management. Arch Dis Child Fetal Neonatal Ed 2003; 88: F359-F364.
8. Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Bakrania L, Llewelyn C, Littlewood T, Soutar R, Norfolk D, Copplestone A, Smith N, Kerr P, Jones G, Raj K, Westerman DA, Szer J, Jackson N, Bardy PG, Plews D, Lyons S, Bielby L, Wood EM, Murphy MF; TOPPS Investigators: A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013; 368: 1771-1780.
9. Wandt H, Shaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, Mahlknecht U, Ho A, Schaich M, Kramer M, Kaufmann M, Leimer L, Schwerdtfeger R, Conradi R, Dölken G, Klenner A, Hänel M, Herbst R, Junghanss C, Ehninger G; Study Alliance Leukemia: Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: An openlabel, multicentre, randomised study. Lancet 2012; 380: 1309-1316.
10. Josephson CD, Su LL, Christensen RD, Hillyer CD, Castillejo MI, Emory MR, Lin Y, Hume H, Easley K, Poterjoy B, Sola-Visner M: Platelet transfusion practices among neonatologists in the United States and Canada: Results of a survey. Pediatrics 2009; 123: 278-285.
11. Cremer M, Sola-Visner M, Roll S, Josephson CD, Yilmaz Z, Bührer C, Dame C: Platelet transfusions in neonates: Practices in the United States vary significantly from those in Austria, Germany and Switzerland. Transfusion 2011; 51: 2634-2641.
12. Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, Watts J, Saigal S, Milner R, Wang E: A randomised controlled trial of platelet transfusions in thrombocytopenic premature infants. Pediatrics 1993; 123: 285-291.
13. von Lindern JS, Hulzebos CV, Bos AF, Brand A, Walther FJ, Lopriore E: Thrombocytopaenia and intraventricular haemorrhage in very premature infants: A tale of two cities. Arch Dis Child Fetal Neonatal Ed 2012; 97: F348-F352.
14. Sola-Visner MC: Platelets in the neonatal period: Developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. Hematology Am Soc Hematol Educ Program 2012; 2012: 506-511.
15. Gibson BE, Todd A, Roberts I, Pamphilon D, Rodeck C, Bolton-Maggs P, Burbin G, Duguid J, Boulton F, Cohen H, Smith N, McClelland DB, Rowley M, Turner G; British Committee for Standards in Haematology Transfusion Task Force: Writing group: Transfusion guidelines for neonates and older children. Br J Haematol 2004; 124: 433-453.
16. Stanworth SJ, Clarke P, Watts T, Ballard S, Coo L, Morris T, Murphy MF, Roberts I: Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009; 124: E826-e834.
17. Muthukumar P, Venkatesh V, Curley A, Kahan BC, Choo L, Ballard S, Clarke P, Watts T, Roberts I, Stanworth S: Severe thrombocytopenia and patterns of bleeding in neonates: Results from a prospective observational study and implications for use of platelet transfusions. Transfus Med 2012; 22: 338-343.
18. Chakravorty S, Roberts I: How I manage neonatal thrombocytopenia. Br J Haematol 2011; 156: 155-162.
19. PlaNeT-2: Study protocol. http://www.planet-2.com/downloads/205/PlaNeT2Protocolv20.pdf
20. pdf. 20 Curley A, Venkatesh V, Stanworth S, Clarke P, Watts T, New H, Willoughby K, Khan R, Muthukumar P, Deary A: Platelets for neonatal transfusion -study 2: A randomized controlled trial to compare two different platelet count thresholds for prophylactic platelet transfusion to preterm neonates. Neonatology 2014; 106: 102-106.
21. Christensen RD, Paul DA, Sola-Visner MC, Baer VL: Improving platelet transfusion practices in the neonatal intensive care unit. Transfusion 2008; 48: 2281-2284.
22. Gerday E, Baeir VL, Lambert DK, Paul DA, Sola-Visner MC, Pysher TJ, Christensen RD: Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Transfusion 2009; 49: 2034-2039.
23. Christensen RD, Carroll PD, Josephson CD: Evidence-based advances in transfusion practice in neonatal intensive care units. Neonatology 2014; 106: 245-253.
24. Burrows RF, Kelton JG: Low fetal risk in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol 1990; 163: 1147-1150.
25. Valat AS, Caulier MT, Devols P, Rugeri L, Wibaut B, Vaast P, Puech F, Bauters F, Jude B: Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia. Br J Haematol 1998; 103: 397-401.
26. Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG: A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003; 102: 4306-4311.
27. Ballin A, Andrew M, Ling E, Perlman M, Blanchette V: High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr 1988; 112: 789-792.
28. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, Hughes D, Jobson S, Ouwehand WH: The natural history of fetomaternal alloimmunization to the plateletspecific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998; 92: 2280-2287.
29. Bussel J: Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009; 17(suppl 1): 253-257.
30. Ghevaert C, Campbell K, Walton J, Smith GA, Allen D, Williamson LM, Ouwehand WH, Ranasinghe E: Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 2007; 47: 901-910.
31. Peterson JA, McFarland JG, Curtis BR, Aster RH: Neonatal alloimmune thrombocytopenia: Pathogenesis, diagnosis and management. Br J Haematol 2013; 161: 3-14.
32. Salomon O, Rosenberg N: Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia. Br J Haematol 2013; 162: 304-312.
33. Ghevaert C, Herbert N, Hawkins L, Grehan N, Cookson P, Garner SF, Crisp-Hihn A, Lloyd-Evans P, Evans A, Balan K, Ouwehand WH, Armour KL, Clark MR, Williamson LM: Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: Proof of principle in human volunteers. Blood 2013; 122: 313-320.
34. Treleaven J, Gennery A, Marsh J, Norfolk D, Page L, Parker A, Saran F, Thurston J, Webb D: Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Br J Haematol 2011; 152: 35-51.
35. Journeycake JM: Childhood immune thrombocytopenia: Role of rituximab, recombinant thrombopoietin, and other new therapeutics. Hematology Am Soc Hematol Educ Program 2012; 2012: 444-449.
36. Arnold DM: Positioning new treatments in the management of immune thrombocytopenia. Pediatr Blood Cancer 2013; 60(suppl 1): S119-S122.
37. Sallmon H, Gutti RK, Ferrer-Marin F, Liu ZJ, Sola-Visner MC: Increasing platelets without transfusion: Is it time to introduce novel thrombopoietic agents in neonatal care? J Perinatol 2010; 30: 765-769.
38. Carr R: The role of colony stimulating factors and immunoglobulin in the prevention and treatment of neonatal infection. Arch Dis Child Fetal Neonatal Ed 2013; 98: 192-194.
39. Lambert MP, Sullivan SK, Fuentes R, French DL, Poncz M: Challenges and promises for the development of donor-independent platelet transfusions. Blood 2013; 121: 3319-3324.